Symptomtext
22-years patient administered FLUZONE QUADRIVALENT HIGH-DOSE /no AE; 22-years patient administered FLUZONE QUADRIVALENT HIGH-DOSE /no AE; receiving FLUZONE QUADRIVALENT HIGH-DOSE on accident due to the administrator not verifying the product prior to administration, original order was not for a high dose but a standard flu vaccine with no adverse event; Initial information received on 01-Dec-2021 regarding an unsolicited valid non-serious case from other health professional via Agency (under the reference: 00880548). This case involves a 22-year-old female patient receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] on accident due to the administrator not verifying the product prior to administration, original order was not for a high dose but a standard flu vaccine with no adverse event (wrong product administered, product administered to patient of inappropriate age, overdose). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Dec-2021, the patient received a 0.7 mL total dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [frequency: once, strength: high dose, lot UJ763AA, expiry date: 30-Jun-2022] via intramuscular route in the left arm for prophylactic vaccination. It was a case of an actual medication error due to wrong vaccine administered, inappropriate age at vaccine administered, overdose (latency same day). At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.